Key facts
- This page summarizes Aetna Wun Trombley's Form 3 filing for Lycia Therapeutics, Inc..
- 0 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 22 Oct 2026, 19:10.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
These securities are held by the Trombley Family Trust of which the Reporting Person and her spouse are trustees.
Footnote F2
The options are fully vested.
Footnote F3
The options vested as to 1/48 of the total award on July 27, 2024, and an additional 1/48 of the award will vest monthly thereafter, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Footnote F4
The options vested as to 1/48 of the total award on February 1, 2026, and an additional 1/48 of the award will vest monthly thereafter, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Footnote F5
The options vested as to 1/48 of the total award on September 6, 2026, and an additional 1/48 of the award will vest monthly thereafter, subject to the Reporting Person's provision of service to the Issuer on each vesting date.